Not all anesthetic techniques fit the questions: editorial fit reflects scientific fit Authors: Susana Vacas, Michele Introna, Francisco Lobo Published: 2026 We thank the authors for their thoughtful response to our editorial, “Admixture of anesthetic drugs in the era of precision monitoring: a dangerous convenience” [1, 2]. We agree with the central premise that editorial fit, physiologic interpretability, and clinical safety are not identical concepts. However, we respectfully disagree that they can be fully separated in the context of precision monitoring. Our use of the term “dangerous” does not imply that every anesthetic delivered using an admixture is inherently unsafe, nor that experienced centers using standardized protocols have necessarily produced excess complications attributable to mixing. Rather, the concern is that admixture creates a latent safety risk by embedding two or more pharmacologically distinct drugs into a single, fixed-ratio delivery system. This limits independent titration, obscures dose-response relationships, and reduces the clinician’s ability to interpret physiologic signals when changes in electroencephalographic activity, hemodynamics, respiratory pattern, or nociceptive responses occur. In this sense, the concern is not simply methodological. It is intrinsically clinical. Precision monitoring depends on the ability to adjust therapy based on patient-specific physiology. When hypnotic and analgesic delivery are mechanically linked, a change intended to modify one pharmacodynamic domain necessarily changes the other. Increasing the infusion to deepen hypnosis also increases opioid delivery; reducing opioid delivery to address bradycardia, hypotension, delayed emergence, or respiratory depression may simultaneously reduce hypnotic delivery. This coupling may be tolerable in selected settings, but it is not pharmacologically neutral. The authors correctly note that published clinical experience with admixtures of anesthetic drugs, including prospective cohort data and their own work, does not demonstrate obvious inherent danger. However, the absence of demonstrated harm is not equivalent to evidence of safety. Observational studies from experienced centers are valuable, but they may not capture rare adverse events, aseptic preparation concerns, infection risk, medication preparation errors, stability issues, pharmacokinetic variability, vulnerable subgroups, or outcomes that are increasingly relevant to precision anesthesia, such as electroencephalographic patterns, burst suppression, delayed emergence, postoperative delirium, or neurocognitive recovery. Moreover, the fact that a practice is widely used across some centers does not, in itself, establish that it is optimal, generalizable, or aligned with the goals of individualized monitoring-guided care or the broader trajectory of modern anesthesia practice. Our editorial position is therefore not that admixture should be categorically prohibited or that all studies using admixture are scientifically invalid. Rather, we argue that in an era moving toward individualized anesthetic delivery, physiologic closed-loop systems, EEG-guided titration, nociception monitoring, and mechanism-informed perioperative care, the practice of combining hypnotic and analgesic agents into a single syringe deserves greater scrutiny. At minimum, studies using admixtures should clearly justify the approach, report preparation methods, drug concentrations, ratios, infusion algorithms, monitoring strategies, and safeguards, and acknowledge the limitations imposed on independent titration and mechanistic inference. We also agree that the evidence base remains incomplete. That incompleteness, however, supports caution rather than reassurance. As the field of anesthesiology increasingly embraces precision monitoring, individualized pharmacology, and data-driven titration, practices that constrain independent drug delivery should not be accepted simply because they are convenient or historically familiar. The burden should not rest solely on demonstrating catastrophic harm before questioning a practice that reduces pharmacologic flexibility and physiologic interpretability. In Bayesian terms, a practice with low prior plausibility — one that contradicts established pharmacokinetic and pharmacodynamic principles — requires extraordinarily strong evidence to justify adoption [3]. Absence of proof of harm is not proof of safety, and in the absence of mechanistic rationale and robust empirical support, parsimony and biological first principles compel us toward the simpler, better-characterised alternative. In patient populations increasingly recognized as heterogeneous in anesthetic pharmacologic sensitivity, including older adults, patients with cognitive vulnerability, frailty, neurologic disease, or altered opioid responsiveness, the ability to titrate hypnotic and analgesic components independently is not merely an academic preference. It is central to the promise of precision anesthesia. In modern anesthesia, safety is no longer defined only by the absence of immediate complications. It also includes the ability to measure, interpret, and respond to individual physiology with clarity. Fixed-ratio admixture should not be viewed as a neutral convenience, but as a practice with inherent limitations in pharmacologic interpretability, mechanistic clarity, and as a conceptual inconsistency with contemporary advances in the field of Anesthesiology [1]. Author contributions All authors wrote and reviewed the manuscript. Data availability No datasets were generated or analysed during the current study. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.